Descrizione del progetto
Formazione per una produzione farmaceutica verde e digitale
L’industria farmaceutica europea sta affrontando una sfida significativa per rendere più ecologici e digitali i propri processi produttivi. La carenza di ingegneri e scienziati preparati ostacola il progresso in questo settore. In proposito, il progetto GreenDigiPharma, finanziato dall’UE, produrrà una coorte di 10 dottori di ricerca altamente qualificati e formati che guideranno la trasformazione verde e digitale della produzione farmaceutica sia in ambito accademico che industriale. Il progetto si concentrerà sulle questioni urgenti della produzione sostenibile ed esplorerà metodi più ecologici per la produzione di prodotti farmaceutici, incorporando tecnologie innovative come i nanocatalizzatori eterogenei e la biocatalisi, nuove tecniche di purificazione e strumenti di digitalizzazione. Il programma GreenDigiPharma fornirà inoltre ai ricercatori in fase iniziale conoscenze scientifiche e trasferibili sui diritti di proprietà intellettuale, sull’imprenditorialità, sulla gestione dei dati e sull’innovazione.
Obiettivo
Greening and digitalizing pharmaceutical manufacturing is one of the grand challenges of Europe's pharma-industry. It offers a significant opportunity to boost productivity, improve competitiveness and reduce the industry large environmental footprint. Current progress is impaired by shortage of trained engineers and scientists, who can design green and digital pharmaceutical processes.
This MSCA doctoral network will focus on addressing these skills gaps, delivering a cohort of highly-skilled and trained PhD graduates that will lead the green and digital transformation of the pharmaceutical manufacturing, both in academic and industrial environments. The consortium brings together 7 universities, 1 research center, and additional 11 associated members from academia and industry. This will address urgent topics in continuous green manufacturing and develop greener routes to prepare pharmaceutical products, promoting the adoption of novel technologies (flow synthesis instead batch methods, heterogeneous nano and biocatalysis in lieu of homogeneous catalysts, renewable carbon sources, novel purification methods, digitalization tools) for sustainable manufacturing.
Specific PhD topics for 10 ESRs have been outlined. The research and training programme will equip the ESRs with key scientific and transferable skills, such as IPR, entrepreneurship, data and innovation management. The consortium strong track record in the management of interdisciplinary research and training will ensure effective and timely training of the next-generation leaders of Europe’s pharma-industries. The exposure to academic and industry sectors will also provide the researchers with unparalleled career opportunities.
Campo scientifico
- natural scienceschemical sciencesorganic chemistry
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- engineering and technologyindustrial biotechnologybioprocessing technologies
- engineering and technologychemical engineeringchemical process engineering
- natural scienceschemical sciencescatalysisbiocatalysis
Parole chiave
Programma(i)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Meccanismo di finanziamento
HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral NetworksCoordinatore
20133 Milano
Italia